Advertisement

Breast Feeding and the Intestinal Microflora of the Infant — Implications for Protection Against Infectious Diseases

  • A. E. Wold
  • I. Adlerberth
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 478)

Abstract

Human breast milk contains an array of factors with anti-infectious potential, such as immunoglobulins (especially secretory IgA), oligosaccharides and glycoproteins with anti-adhesive capacity, and cytokines. Breast-feeding is associated with protection from the following infections or infection-related conditions: gastroenteritis, upper and lower respiratory tract infection, acute otitis media, urinary tract infection, neonatal septicaemia and necrotizing enterocolitis. Some of the protective effects may derive from an altered mucosal colonization pattern in the breast-fed infant. In other instances breast-fed infants develop less symptoms to the same microbe which causes disease in the bottle-fed infant. An example of an altered colonization pattern is that breast-fed infants have less P-fimbriated, but more type 1-fimbriated E. coli. This may protect against urinary tract infection in the breast-fed infant since P fimbriae are the major virulence factor for urinary tract infection. An example of changed consequences of the same microbial colonization is that secretory IgA in the breast-milk protects very efficiently from translocation of intestinal bacteria across the gut mucosa by coating intestinal bacteria and blocking their interaction with the epithelium. This mechanism may protect the infant from septicaemia of gut origin and, possibly, necrotizing enterocolitis. Breast-milk is also highly anti-inflammatogenic and contains hormone like factors which counteract diarrhea. Thus, breast-fed infants may be colonized by recognized diarrheal pathogens and still remain healthy. Due to a less virulent intestinal microflora and decreased translocation breast-fed infants will obtain less stimuli for the gut immune system, resulting, in e.g.,lower salivary IgA antibody titres.

Key words

Milk human IgA secretory large intestine bacterial adherence 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Defense factors in human milk. Wold AE, Hanson LÅ Curr.Opin. Gastroenterol. 1994,10:652.Google Scholar
  2. 2.
    Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Victora CG, Smith PG, Vaughan JP, et al. Lancet 1987,ii:319.Google Scholar
  3. 3.
    Health care costs of formula-feeding in the first year of life. Ball TM, Wright AL Pediatrics 1999,103(4 Pt 2):870.PubMedGoogle Scholar
  4. 4.
    Proteolytic degradation of exocrine and serum immunoglobulins. Brown WR, Newcomb RW, Ishizaka IK J. Clin. Invest. 1970,49:1374.PubMedGoogle Scholar
  5. 5.
    Studies on the structural and conformational basis for the relative resistance of serum and secretory immunoglobulin A to proteolysis. Underdown BJ, Dorrington KJ J. Immunol. 1974,112:949.PubMedGoogle Scholar
  6. 6.
    Biological functions of oligosaccharides in human milk. Kunz C, Rudloff S Acta Paediatr. 1993,82:902.Google Scholar
  7. 7.
    Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination). Holmgren J, Svennerholm AM, Lindblad M Infect. Immun. 1983,39:147.PubMedGoogle Scholar
  8. 8.
    Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. Andersson B, Porras O, Hanson LÅ, Lagergård T, Svanborg Edén C J. Infect. Dis. 1986,153:232.PubMedGoogle Scholar
  9. 9.
    Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Wold AE, Mestecky J, Tomana M, et al. Infect. Immun. 1990,58:3073.PubMedGoogle Scholar
  10. 10.
    Secretory immunoglobulin A heavy chains presents Gal[]/GalNAc[] binding structures for Actinomyces naeslundii genospecies 1. Bratt P, Borén T, Strömberg N J. Dent. Res. 1999,78:1238.PubMedGoogle Scholar
  11. 11.
    Structure of the carbohydrate moieties of secretory component purified from human milk. Mizoguchi A, Mizouchi T, Kobata A J. Biol. Chem. 1982,257:9612.PubMedGoogle Scholar
  12. 12.
    Attachment of Helicobacter pylori to gastric epithelium mediated by blood group antigens. Borén T, Falk P, Roth KA, Larsson G, Normark S Science 1994,262:1892.Google Scholar
  13. 13.
    Inhibition of adhesion of S-fimbriated E. coli to buccal epithelial cells by human skim milk is predominantly mediated by mucins and depends on the period of lactation. Schroten H, Plogmann R, Hanish FG, Hacker J, Nobis-Bosch R, Wahn V Acta Paediatr. 1993,82:6.PubMedGoogle Scholar
  14. 14.
    Serotypes, hemolysin production and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Korhonen TK, Valtonen MV, Parkkinen J, et al. Infect. Immun. 1985,48:486.PubMedGoogle Scholar
  15. 15.
    Isolation of interleukin-1 from human milk. Söder 0 Int. Arch. Allergy Appl. Immunol. 1987,83:19.Google Scholar
  16. 16.
    Tumor necrosis factor-alpha in human milk. Rudloff HE, Schmalstieg FC, Mushtaha AA, Palkowetz KH, Liu SK, Goldman AS Pediatr. Res. 1992,31:29.PubMedGoogle Scholar
  17. 17.
    Interleukin-6 in human milk. Rudloff HE, Schmalstieg Jr FC, Palkowetz KH, Paszkiewicz EJ, Goldman AS J. Reprod. Immunol. 1993,23:13.Google Scholar
  18. 18.
    Presence of interferon-gamma and interleukin-6 in colostrum of normal women. Bocci V, von Bremen K, Corradeschi F, Franchi F, Luzzi E, Paulesu L Lymphokine Cytokine Res. 1993,12:21.PubMedGoogle Scholar
  19. 19.
    Interleukin-10 in human milk. Garofalo R, Chheda S, Mei F, et al. Paediatr. Res. 1995, 37(4 Pt 1):444.CrossRefGoogle Scholar
  20. 20.
    Human milk contains granulocyte colony stimulating factor. Gilmore WS, McKelvey-Martin VJ, Rutherford S, et al. Eur. J. Clin. Nutr. 1994,48:222.PubMedGoogle Scholar
  21. 21.
    Interleukin-12 in human milk. Bryan DL, Hawkes JS, Gibson RA Pediatr. Res. 1999,45:858.PubMedGoogle Scholar
  22. 22.
    Oral cytokine administration. Rollwagen FM, Baqar S Immunol. Today 1996,17:548.PubMedCrossRefGoogle Scholar
  23. 23.
    Adlerberth I, Hanson LA, Wold AE. The ontogeny of the intestinal flora. In Development of the gastrointestinal tract, Edited by Sanderson IR, Walker WA. Hamilton, Ontario: B.C. Decker; 1999Google Scholar
  24. 24.
    Freter R. Mechanisms that control the microflora of the large intestine. In Human intestinal microflora in health and disease, Edited by Hentges DJ. New York: Academic Press; 1983:33.Google Scholar
  25. 25.
    Midtvedt A-C. The establishment and development of some metabolic activities associated with the intestinal microflora in healthy children. Thesis. Stockholm, 1994.Google Scholar
  26. 26.
    The fecal flora of children in the United Kingdom. Ellis-Pegler RB, Crabtree C, Lambert HP J. Hyg. (Camb.) 1975,75:135.Google Scholar
  27. 27.
    Influence of maternal gut flora and colostral and cord serum antibodies on presence of Escherichia coli in faeces of the newborn infant. Gothefors L, Carlsson B, Ahlstedt S, Hanson LA, Winberg J Acta Paediatr. Scand. 1976,65:225.Google Scholar
  28. 28.
    The acquisition of Escherichia coli by newborn babies. Bettelheim KA, Lennox-King SMJ Infection 1976,4:174.PubMedCrossRefGoogle Scholar
  29. 29.
    Importance of the environment and the faecal flora of infants, nursing staff and parents as sources of Gram-negative bacteria colonizing newborns in three neonatal wards. Fryklund B, Tullus K, Berglund B, Burman LG Infection 1992,20:253.PubMedCrossRefGoogle Scholar
  30. 30.
    Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants. Adlerberth I, Carlsson B, de Man P, et al. Acta Paediatr. Scand. 1991,80:602.PubMedGoogle Scholar
  31. 31.
    High turn-over rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Adlerberth I, Jalil F, Carlsson B, et al. Epidemiol. Infect. 1998,121:587.PubMedGoogle Scholar
  32. 32.
    Reduction in bacterial contamination in banked human milk. Asquith MT, Harrod JR J. Pediatr. 1979,95:993.PubMedGoogle Scholar
  33. 33.
    Escherichia coli serogroups in breast-fed and bottle-fed infants. Orskov F, Biering Sorensen K Acta Path. Microbiol. Scand. Sect. B 1975,83:25.Google Scholar
  34. 34.
    Effect of iron on serotypes and hemagglutination patterns of Escherichia coli in bottle-fed infants. Mevissen-Verhage EAE, Marcelis JH, Guiné PAM, Verhoe J Eur. J. Clin. Microbiol. 1985,4:570.PubMedGoogle Scholar
  35. 35.
    Fecal colonization with P-fimbriated E. coli between 0 and 18 months of age. Tullus K Epidemiol. Infect. 1988,100:185.PubMedCrossRefGoogle Scholar
  36. 36.
    The antibody response in breast-fed and non-breast-fed infants after artificial colonization of the intestine with Escherichia coli O83. Lodinová-Zádníková R, Slavíková M, Tlaskalová-Hogenová H, et al. Pediatr. Res. 1991,29:396.PubMedGoogle Scholar
  37. 37.
    Increased mannose-specific adherence and colonizing ability of E. coli O83 in breast-fed infants. Slavikova M, Lodinová-Zadniková R, Adlerberth I, Hanson LÅ, Svanborg C, Wold AE Adv. Exp. Med. Biol. 1995,371A:421.PubMedGoogle Scholar
  38. 38.
    Mannose-resistant hemagglutination (MRHA) and haemolysin production of strains of Escherichia coli isolated from children with diarrhoea: effect of breastfeeding. Giugliano LG, Meyer CJ, Arantes LC, Ribeiro ST, Giugliano R J. Trop. Pediatr. 1993,39:183.PubMedGoogle Scholar
  39. 39.
    Breast feeding and biological properties of faecal E. coli strains. Gothefors L, Olling S, Winberg J Acta Paediatr. Scand. 1975,64:807.PubMedGoogle Scholar
  40. 40.
    Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. Robbins JB, McCracken GHJ, Gotschlich EC, Orskov F, Orskov I, Hanson LÅ N. Engl. J. Med. 1974,290:1216.PubMedCrossRefGoogle Scholar
  41. 41.
    Tissier H. Recherches sur la flore intestinale des nourrissons(état normal et pathologique). Paris, 1900.Google Scholar
  42. 42.
    Berg RD. Translocation of indigenous bacteria from the intestinal tract. In Intestinal microflora in health and disease, Edited by Hentges DJ. New York: Acad. Press; 1983: 333.Google Scholar
  43. 43.
    Role of Escherichia coli P fimbriae in intestinal colonization in gnotobiotic rats. Herias MV, Midtedt T, Hanson LA, Wold AE Infect. Immun. 1995,63:4781.PubMedGoogle Scholar
  44. 44.
    Escherichia coli K5 capsule expression enhances colonization of the large intestine in the gnotobiotic rat. Herias MV, Midtvedt T, Hanson LA, Wold AE Infect. Immun. 1997,65531.Google Scholar
  45. 45.
    Asymptomatic bacteriemia in the newborn infant. Albers WH, Tyler CW, Boxerbaum B J.Pediatr. 1966,159193.Google Scholar
  46. 46.
    Bacterial translocation in the neonate. Van Camp JM, Tomaselli V, Coran AG Curr. Opin. Pediatr. 1994,6:327.PubMedGoogle Scholar
  47. 47.
    Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice. Owens WE, Berg RD Infect. Immun. 1980,27:461.PubMedGoogle Scholar
  48. 48.
    Bacterial translocation from the gastrointestinal tracts of thymectomized mice. Owens WE, Berg RD Curr. Microbiol. 1982,7:169.CrossRefGoogle Scholar
  49. 49.
    The normal microbial flora as a major stimulus for proliferation of plasma cells synthesizing IgA in the gut. Crabbé PA, Bazin H, Eyssen H, Heremans JF Int. Arch. Allergy 1968,34:362.PubMedGoogle Scholar
  50. 50.
    Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice. Crabbé PA, Nash DR, Bazin H, Eysseb H, Heremans JF Lab. Invest. 1970,22:448.PubMedGoogle Scholar
  51. 51.
    Effect of early nutritional deprivation and diet on translocation of bacteria from the gastro-intestinal tract in the newborn rat. Steinwender G, Schimpl G, Sixl B, et al. Pediatr. Res. 1995,39:415.Google Scholar
  52. 52.
    Breast milk protects the neonate from bacterial translocation. Go LL, Albanese CT, Watkins SC, Simmons RL, Rowe MI J. Pediatr. Surg. 1994,29:1059.PubMedCrossRefGoogle Scholar
  53. 53.
    Quantitative and morphologic analysis of bacterial translocation in neonates. Go LL, Ford HR, Watkins SC, et al. Arch. Surg. 1994,129:1184.PubMedGoogle Scholar
  54. 54.
    Escherichia coli S fimbriae in intestinal colonization and translocation. Herias MV, Robertson A-K, Midtvedt T, Wold AE In manuscript 1999Google Scholar
  55. 55.
    Effect of secretory IgA on transepithelial passage of bacteria across the intact ileum in vitro. Albanese CT, Smith SD, Watkins S, Kurkchubasche A, Simmons RL, Rowe MI J. Am. Coll. Surg. 1994,179:679.PubMedGoogle Scholar
  56. 56.
    The protective role of enteral IgA supplementation in neonatal gut origin sepsis. Maxson RT, Jackson RJ, Smith SD J. Pediatr. Surg. 1995,30:231.PubMedCrossRefGoogle Scholar
  57. 57.
    Immunoglobulin A supplementation abrogates bacterial translocation and preserves the architecture of the intestinal epithelium. Dickinson EC, Gorga JC, Garrett M, et al. Surgery 1998,124:284.PubMedGoogle Scholar
  58. 58.
    The effect of epidermal growth factor on bacterial translocation in newborn rabbits. Okuyama H, Urao M, Lee D, Drongowski RA, Coran AG J. Pediatr. Surg. 1998,33:225.PubMedGoogle Scholar
  59. 59.
    Systemic sepsis following hemorrhagic shock: alleviation with oral interleukin-6. Rollwagen FM, Li YY, Pacheco ND, Baqar S Mil. Med. 1997,162:366.PubMedGoogle Scholar
  60. 60.
    Differential modulation of the immune response by breast-or formula-feeding of infants. Pabst HF, Spady DW, Pilarski LM, Carson MM, Beeler JA, Krezolek MP Acta Pediatr 1997,86:1291.Google Scholar
  61. 61.
    Serum immunoglobulins in preterm infants: comparison of human milk and formula feeding. Savilahti E, Jarvenpaa AL, Raiha MC Pediatrics 1983,72:312.PubMedGoogle Scholar
  62. 62.
    Serum and saliva Ig-levels in infants of non-atopic mothers fed breast milk or cow’s milk-based formulas. Ostergaard PA Acta Paediatr. Scand. 1985,74:555.PubMedGoogle Scholar
  63. 63.
    Breastfeeding conditions a differential developmental pattern of mucosal immunity. Gleeson M, Cripps AW, Clancy RL, Hensley MJ, Dobson AJ, Firman DW Clin. Exp. Immunol. 1986,66216.Google Scholar
  64. 64.
    Development of secretory immunity in breast fed and bottle fed infants. Stephens S Arch. Dis. Child. 1986,61:263.PubMedCrossRefGoogle Scholar
  65. 65.
    Immunoglobulin A subclasses in infants’ saliva and milk from their mothers. Fitzsimmons SP, Evans MK, Pearce CL, Sheridan MJ, Wientzen R, Cole MF J. Pediatr. 1994,124:566.PubMedGoogle Scholar
  66. 66.
    In-vivo immune responses of breast-and bottle-fed infants to tetanus toxoid antigen and to normal gut flora. Stephens S, Kennedy CR, Lakhani PK, Brenner MK Acta Paediatr. 1984,73:426.Google Scholar
  67. 67.
    Early child health in Lahore, Pakistan: X. Mortality. Khan SR, Jalil F, Zaman S, Lindblad BS, Karlberg J Acta Paediatr. Suppl. 1993,390:109.Google Scholar
  68. 68.
    Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Sarff LD, McCracken Jr GH, Schiffer MS, et al. Lancet 1975,i:1099.Google Scholar
  69. 69.
    Molecular analysis provides evidence for the endogenous origin of bacteremia and meningitis due to Enterobacter cloaceae in an infant. Lambert-Zechovsky N, Bingen E, Denamur E, et al. Clin. Infect. Dis. 1992,15:30.PubMedGoogle Scholar
  70. 70.
    New models for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholera infection. Winner III L, Mack J, Weltzin R, Mekalanos JJ, Kraehenbuhl JP, Neutra MR Infect. Immun. 1991,59:977.PubMedGoogle Scholar
  71. 71.
    Influence of breast milk on nosocomial rotavirus infections in infants. Berger R, Hadziselimovic F, Just M, Reigel F Infection 1984,12:171.PubMedCrossRefGoogle Scholar
  72. 72.
    Effect of breast-feeding on morbitidy in rotavirus gastroenteritis. Weinberg RJ, Tipton G, Klish WJ, Brown MR Pediatrics 1984,74:250.PubMedGoogle Scholar
  73. 73.
    Rotavirus serology and breast-feeding in young children in rural Guinea-Bissau. Gunnlaugsson G, Smedman L, da Silva MC, Grandien M, Zetterstrom R Acta Paediatr. Scand. 1989,78:62.PubMedGoogle Scholar
  74. 74.
    Rotavirus infections in young Nicaraguan children. Espinoza F, Paniagua M, Hallander H, Svensson L, Strannegard O Pediatr. Infect. Dis. J. 1997,16:564.PubMedGoogle Scholar
  75. 75.
    Breast-feeding and the risk of life-threatening rotavirus diarrhea: prevention or postponement? Clemens J, Rao M, Ahmed F, et al. Pediatrics 1993,92:680.PubMedGoogle Scholar
  76. 76.
    Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. Ruggeri FM, Johansen K, Basile G, Kraehenbuhl JP, Svensson L J. Virol. 1998,72:2708.Google Scholar
  77. 77.
    Protective effect of rotavirus VP6-specificIgAmonoclonal antibodies that lack neutralizing activity. Bums JW, Siadat-Pjouh M, Krishnaney AA, Greenberg HB Science 1996,272:104.Google Scholar
  78. 78.
    Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. Yolken RH, Peterson JA, Vonderfecht SL, Fouts ET, Midthun K, Newburg DS J. Clin. Invest. 1992,90:1984.PubMedGoogle Scholar
  79. 79.
    Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Newburg DS, Peterson JA, Ruiz-Palacios GM, et al. Lancet 1998,351: 1160.PubMedGoogle Scholar
  80. 80.
    Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Apter FM, Michetti P, Winner III LS, Mack JA, Mekalanos JJ, Neutra MR Infect. Immun. 1993,61:5279.PubMedGoogle Scholar
  81. 81.
    Studies on the mechanism of action of intestinal antibody in experimental cholera. Freter R Texas Rep. Biol. Med. 1969,27(Suppl. 1):299.Google Scholar
  82. 82.
    Growth advantage and enhanced toxicity of Escherichia coli adherent to tissue culture cells due to restricted diffusion of products secreted by the cells. Zafriri D, Oron Y, Eisenstein B, Ofek I J. Clin. Invest. 1987,79:1210.PubMedCrossRefGoogle Scholar
  83. 83.
    Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR Infect. Immun. 1992,60:1786.PubMedGoogle Scholar
  84. 84.
    Passive secretory immunity against Salmonella typhimurium demonstrated with foster mouse pups. Shope SR, Schiemann DA J. Med. Microbiol. 1991,3553.Google Scholar
  85. 85.
    In vivo IgA coating of anaerobic bacteria in human feces. van der Waaij LA, Limburg PC, Mesander G, van der Waaij D Gut 1996,38:348.PubMedGoogle Scholar
  86. 86.
    Observations on the pathogenic properties of the K88, HLY and ENT plasmids of Escherichia coli with particular reference to porcine diarrhoea. Smith HW, Linggood MA J. Med. Microbiol. 1971,4:467.PubMedGoogle Scholar
  87. 87.
    Wold AE. Role of bacterial adherence in the establishment of the normal intestinal microflora. In Probiotics, other nutritional factors, and intestinal microflora, Edited by Hanson LA, Yolken RH. Philadelphia: Vevey/Lipincott-Raven Publishers; 1999: 47. Nestlé Nutrition Workshop Series; vol42).Google Scholar
  88. 88.
    The uniqueness of human milk. Host resistance to infection. Mata LJ, Wyatt RG Am. J. Clin. Nutr. 1971,24:976.PubMedGoogle Scholar
  89. 89.
    Mata JL. The children of Santa Maria Cauqué. A prospective field study of health and growth. Cambridge, Massachussets: MIT Press, 1978:395.; vol XVII).Google Scholar
  90. 90.
    The antisecretory factors: inducible proteins which modulate secretion in the small intestine. Lönnroth I, Lange S, Skadhauge E Comput. Biochem. Physiol. 1988,90A:611.Google Scholar
  91. 91.
    A hormone-like protein from the pituitary gland inhibits intestinal hypersecretion induced by cholera toxin. Lönnroth I, Lange S Regulatory Peptides Suppl. 1985,4:216.Google Scholar
  92. 92.
    Evidence of protection against diarrhoea in suckling piglets by a hormone-like protein in the sow’s milk. Lönnroth I, Martinsson K, Lange S J. Vet. Med. 1988,35:628.Google Scholar
  93. 93.
    Bacterial virulence versus host resistance in the urinary tracts of mice. Svanborg Edén C, Hagberg L, Hull R, Hull S, Magnusson K-E, Öhman L Infect. Immun. 1987,55:1224.PubMedGoogle Scholar
  94. 94.
    Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. Wold AE, Caugant DA, Lidin-Janson G, de Man P, Svanborg C J. Inf. Dis. 1992,165:46.Google Scholar
  95. 95.
    The importance of P and type 1 fimbriae for the persistence of Escherichia coli in the human gut. Tullus K, Kühn I, Ørskov I, Ørskov F, Möllby R Epidemiol. Infect. 1992,108:415.PubMedCrossRefGoogle Scholar
  96. 96.
    P fimbriae and other adhesins enhance intestinal persistence of Escherichia coli in early infancy. Adlerberth I, Svanborg C, Carlsson B, et al. Epidemiol. Infect. 1998,121:599.PubMedGoogle Scholar
  97. 97.
    Intestinal carriage of P-fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. Plos K, Connell H, Jodal U, et al. J. Infect. Dis. 1995,171Google Scholar
  98. 98.
    Breastfeeding and urinary tract infection. Piscane A, Graziano L, Zona G Lancet 1990,336:50.Google Scholar
  99. 99.
    Breast-feeding and urinary-tract infection. Mårild S, Jodal U, Hanson LÅ Lancet 1990,336:942.PubMedGoogle Scholar
  100. 100.
    Exclusive breastfeeding protects against bacterial colonization and day care exposure to otitis media. Duffy LC, Faden H, Wasiliewski R, Wolf J, Krystofik D Pediatrics 1997,100:E7.PubMedCrossRefGoogle Scholar
  101. 101.
    Antibodies to pneumococcal polysaccharides in human milk: lack of relationship to colonization and acute otitis media. Rosen IA, Hakansson A, Aniansson G, et al. Pediatr. Infect. Dis. J. 1996,15:498.PubMedGoogle Scholar
  102. 102.
    Human milk secretory IgA antibodies to nontypeable Haemophilus influenzae: possible protective effects against nasopharyngeal colonization. Harabuchi Y, H. F, Yamanaka N, Duffy L, Wolf J, Krystofik D J. Pediatr. 1994,124:193.Google Scholar
  103. 103.
    A prospective cohort study on breast-feeding and otitis media in Swedish infants. Aniansson G, Alm B, Andersson B, et al. Pediatr. Infect. Dis. J. 1994,13:183.PubMedGoogle Scholar
  104. 104.
    Epidemiology of necrotizing enterocolitis. Kosloske AM Acta Paediatr. Scand. Suppl. 1994,396:2.Google Scholar
  105. 105.
    Necrotizing enterocolitis. Albanese CT, Rowe MI Semin. Pediatr. Surg. 1995,4:200.PubMedGoogle Scholar
  106. 106.
    Necrotizing enterocolitis in infancy. Kleinhaus S, Weinberg G, Gregor MB Surg. Clin. North Am. 1992,72:261.PubMedGoogle Scholar
  107. 107.
    Antioxidant properties of human colostrum. Buescher ES, McIlheran SM Pediatr. Res. 1988,24:14.PubMedGoogle Scholar
  108. 108.
    Further characterization of human colostral antioxidants. Buescher ES, McIlheran SM, Frenck RW Pediatr. Res. 1989,25:266.PubMedGoogle Scholar
  109. 109.
    Inhibition of receptor-dependent and receptor-independent generation of the respiratory burst in human neutrophils and monocytes by human serum IgA. Wolf HM, Vogel E, Fischer MB, Rengs H, Schwartz HP, Eibl MM Pediatr. Res. 1994,36:235.PubMedGoogle Scholar
  110. 110.
    Anti-inflammatory properties of human serum IgA:induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediateddown-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes. Wolf HM, Hauber I, Gulle H, et al. Clin. Exp. Immunol. 1996,105:537.PubMedCrossRefGoogle Scholar
  111. 111.
    Neonatal necrotizing colitis, a disease of the immature intestinal mucosal barrier. Israel EJ Acta Paediatr. Suppl. 1994,396:27.PubMedGoogle Scholar
  112. 112.
    Prolonged breast feeding, diarrhoeal disease, and survival of children in Guinea-Bissau. Molbak K, Gottschau A, Aaby P, Hojlyng N, Ingholt L, da Silva AP BMJ 1994,308:1403.PubMedGoogle Scholar
  113. 113.
    Mortality and infectious disease associated with infant-feeding practices in developing countries. Jason JM, Nieburg P, Marks JS Pediatrics 1984,74:702.PubMedGoogle Scholar
  114. 114.
    Review of the epidemiologic evidence for and association between infant feeding and infant health. Kovar MG, Sedula MK, Marks JS, Frase DW Pediatrics 1984,74:615.PubMedGoogle Scholar
  115. 115.
    Case-control study of risk of dehydrating diarrhoea in infants in vulnerable period after full weaning. Fuchs SC, Victora CG, Maritnez J BMJ 1996,313:391.PubMedGoogle Scholar
  116. 116.
    Breast feeding and protection against neonatal sepsis in a high risk population. Ashraf RN, Jalil F, Zaman S, et al. Arch. Dis. Child. 1991,66:488.PubMedGoogle Scholar
  117. 117.
    Does breast milk protect against septicemia in the newborn? Winberg J, Wessner G Lancet 1971,i:1091.Google Scholar
  118. 118.
    Prolonged breast feeding as prophylaxis for recurrent otitis media. Saarinen UM Acta Paediatr. Scand. 1982,71:567.PubMedGoogle Scholar
  119. 119.
    Exclusive breast-feeding for at least 4 months protects against otitis media. Duncan B, Ey J, Holberg CJ, Wright AL, Martinez FD, Taussig LM Pediatrics 1993,91:867.PubMedGoogle Scholar
  120. 120.
    Breast-feeding and urinary tract infection. Piscane A, Graziano L, Mazzarella G, Scarpellino B, Zona G J. Pediatr. 1992,120:87.Google Scholar
  121. 121.
    Breast milk and neonatal necrotising enterocolitis. Lucas A, Cole TJ Lancet 1990,336:1519.PubMedCrossRefGoogle Scholar
  122. 122.
    The composition of the faecal microflora in breastfed and bottle fed infants from birth to eight weeks. Lundequist B, Nord CE, Winberg J Acta Paediatr. Scand. 1985,74:45.PubMedGoogle Scholar
  123. 123.
    Diet and faecal flora in the newborn: breast milk and infant formula. Balmer SE, Wharton BA Arch. Dis. Child. 1989,64:1672.Google Scholar
  124. 124.
    Effect of feeding on infants’ faecal flora. Simhon A, Douglas JR, Drasar BS, Soothill JF Arch. Dis. Child. 1982,5754.Google Scholar
  125. 125.
    The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. Stark PL, Lee A J. Med. Microbiol. 1982,15:189.PubMedCrossRefGoogle Scholar
  126. 126.
    Diet and faecal flora in the newborn: nucleotides. Balmer SE, Hanvey LS, Wharton BA Arch. Dis. Child. 1994,70:F137.Google Scholar
  127. 127.
    Effect of various milk feeds on numbers of Escherichia coli and Bifidobacterium in the stools of new-born infants. Hewitt JH, Rigby J J. Hyg., Camb. 1976,77:129.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • A. E. Wold
    • 1
  • I. Adlerberth
    • 1
  1. 1.Department of Clinical ImmunologyGoteborg UniversityGoteborgSweden

Personalised recommendations